Tempus AI (NASDAQ:TEM) Given New $57.00 Price Target at Loop Capital

Tempus AI (NASDAQ:TEM) had its price objective lifted by Loop Capital from $48.00 to $57.00 in a research note released on Tuesday morning, Benzinga reports. Loop Capital currently has a buy rating on the stock.

Several other analysts have also recently issued reports on TEM. Needham & Company LLC reissued a buy rating and set a $47.00 price target on shares of Tempus AI in a research report on Wednesday, August 7th. Morgan Stanley started coverage on shares of Tempus AI in a research report on Tuesday, July 9th. They issued an overweight rating and a $44.00 price target for the company. William Blair began coverage on Tempus AI in a research report on Tuesday, July 9th. They set an outperform rating on the stock. TD Cowen assumed coverage on Tempus AI in a report on Tuesday, July 9th. They issued a buy rating and a $50.00 target price for the company. Finally, Stifel Nicolaus initiated coverage on Tempus AI in a report on Tuesday, July 9th. They set a buy rating and a $45.00 price target on the stock. Two investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of Moderate Buy and an average target price of $48.67.

Tempus AI Stock Performance

Shares of TEM stock opened at $46.63 on Tuesday. The company has a current ratio of 3.70, a quick ratio of 3.52 and a debt-to-equity ratio of 4.50. The business has a 50 day moving average of $51.67. Tempus AI has a one year low of $22.89 and a one year high of $77.00.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings results on Tuesday, August 6th. The company reported ($6.77) EPS for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The firm had revenue of $165.97 million during the quarter, compared to analyst estimates of $159.10 million. On average, research analysts forecast that Tempus AI will post -6.51 earnings per share for the current year.

Institutional Investors Weigh In On Tempus AI

Several institutional investors have recently added to or reduced their stakes in the business. Sandia Investment Management LP purchased a new position in Tempus AI in the second quarter valued at approximately $136,000. Northwestern University acquired a new position in shares of Tempus AI in the 2nd quarter valued at $491,000. Squarepoint Ops LLC purchased a new position in shares of Tempus AI in the 2nd quarter valued at $633,000. WINTON GROUP Ltd acquired a new stake in Tempus AI during the 2nd quarter worth $634,000. Finally, Scientech Research LLC purchased a new stake in Tempus AI in the second quarter valued at $756,000.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.